Addressing Medical Challenges
732 articles related to "Addressing Medical Challenges"
Landing Page Manual – Last updated 13 March 2017
Landing Page Manual – Last updated 31 December 2014
On the 28th November - 4th December 2014, MSF will be attending ASLM 2014. The conference will be a platform where the international laboratory community will share best practices, acquire knowledge,...
Events & Presentations – Last updated 04 November 2014
Background: On 27 August 2014, the European Commission (EC) and the European Medicines Agency (EMA) became the second stringent regulatory authority (after Japan in July) to approve new direct-acting...
Statements, Speeches, Letters – Last updated 27 August 2014
Ma Khin Khin* is a mother of four from Palauk township, around 130 kilometres south of Dawei in Myanmar’s Tanintharyi region. She is the very first MSF patient in Myanmar to receive the...
Web article – Last updated 23 July 2014
Vaccination and treatment must be urgently expanded to stem the epidemic N’djamena/Geneva 1 April 2014: Efforts to contain an ongoing measles epidemic affecting the Chadian capital of N’djamena...
Press Release – Last updated 04 April 2014
URGENT ACTION NEEDED TO TACKLE GLOBAL DRUG-RESISTANT TB THREAT Geneva, 21 March 2014 - A new briefing paper by Médecins Sans Frontières/Doctors Without Borders (MSF) outlines why the...
Press Release – Last updated 20 August 2014
4 March, 2014, Geneva - French pharmaceutical company Sanofi Pasteur has announced a deal with UNICEF to supply significant quantities of its inactivated polio vaccine (IPV) to countries on a tiered...
Statements, Speeches, Letters – Last updated 04 March 2014
In a Hindu BusinessLine article dated 3 February 2014, Gilead indicated it would charge $2,000 per 24 week treatment course for the hepatitis C drug sofosbuvir that was recently approved by both the...
Statements, Speeches, Letters – Last updated 07 February 2014
Pathway to affordable, quality-assured sources of pegylated interferon alpha for treating hepatitis C
Introduction: The current pipeline of promising oral hepatitis C drugs could lead to a revolution in treatment for this disease in both developed and developing countries. At present, the recommended...
In Medical Journals / Research Articles – Last updated 07 February 2014